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Exposure to cadmium confers increased cardiovascular risk. Tobacco smoke contains cadmium, which, hypothetically, may mediate parts of the tobacco-associated risk of developing atherosclerotic plaques. Baseline data from the Swedish Malmö Diet and Cancer cohort (1991) (1992) (1993) (1994) (1995) (1996) were used to test this hypothesis. Mediation analysis was used to examine associations between smoking and blood cadmium levels and the prevalence of ultrasoundassessed carotid atherosclerotic plaques. The total association with smoking status (never smokers, 2 categories of former smokers, and current smokers) was split into direct and indirect association, and the proportion mediated was estimated. The adjusted estimated plaque prevalence was approximately 27% among never smokers. We identified both a direct and an indirect pathway between smoking and carotid plaques; the indirect association, through cadmium, was observed among current smokers and former smokers who had quit smoking less than 15 years before. For current smokers, the prevalence ratio for plaque was 1.5, with 60%-65% of the association with smoking being mediated through cadmium. Recent former smokers had a prevalence ratio of 1.3, and 40%-45% was mediated through cadmium. Long-time former smokers had a prevalence ratio of 1.2, but none of the association was mediated through cadmium. In conclusion, about two-thirds of the proatherosclerotic association with smoking was mediated by cadmium. atherosclerotic plaques; cadmium exposure; indirect effect; mediation; smoking Abbreviations: Cd, cadmium; HDL, high-density lipoprotein cholesterol; hs-CRP, high-sensitivity C-reactive protein; NDE, natural direct effect; NIE, natural indirect effect; PD, prevalence difference; PR, prevalence ratio; TE, total effect.
Myocardial infarction and many cases of stroke are caused by atherosclerosis. The pivotal lesion of this disease process is the subintimal plaque in the artery wall. These plaques may rupture and result in atherothrombosis and acute clinical events. On top of typical cardiovascular risk factors, cadmium (element symbol, Cd) exposure has emerged as an environmental factor that seems to increase cardiovascular risk (1, 2) .
The general population is exposed to cadmium via food items such as rice, wheat, vegetables, and potatoes (3) . Smokers are further exposed as cadmium in tobacco smoke is effectively absorbed in the lungs. In blood, almost all cadmium is bound in erythrocytes. Cadmium is accumulated mainly in the kidneys, with a half-life of decades. Cadmium in blood is affected by recent exposure, but at stable environmental exposure it reflects the body burden (3, 4) .
In animal studies, cadmium exposure promotes the atherosclerotic process (5-7). Endothelial damage (5, 6, 8) , increased apoptosis (5), inflammation (6) , and oxidative stress (8) have been observed as different proatherosclerotic effects of cadmium exposure. It has not been clarified whether or how these mechanisms interact in the atherosclerotic process.
In epidemiologic studies, cadmium levels in blood or urine are associated with cardiovascular death, myocardial infarction, and stroke as well as the prevalence and size of subclinical atherosclerotic plaques in carotid arteries in the general population (1, (9) (10) (11) (12) (13) . Blood cadmium levels in patients with symptomatic carotid plaques correlate with cadmium concentrations in the plaques, which are 50-fold higher than those in blood (14) .
A key issue is the confounding effect of smoking. Tobacco smoke is both an important source of cadmium exposure and a strong risk factor for cardiovascular disease (15) . It has been suggested that cadmium explains, in part, why smokers have an increased risk of cardiovascular disease (16) . Performing subgroup analyses of never smokers has the disadvantage that the average level of cadmium exposure does not reach the levels found in current or previous smokers (12) . Previous studies of the association between cadmium exposure and atherosclerotic diseases have not clarified whether there is a threshold for proatherosclerotic cadmium effects on the arterial wall (1, (11) (12) (13) .
Using mediation analysis, we explored the degree to which the association between smoking and plaque risk is explained indirectly by cadmium exposure (17, 18) . A previous study showed that cadmium exposure via smoking explained 9% of the excess lung cancer mortality linked to tobacco smoking (19) . Moreover, a study of atherosclerotic peripheral artery disease, using ankle-brachial index, found that the odds ratio for smoking decreased substantially when also adjusted for cadmium, indicating that part of the effect of smoking was mediated by cadmium (20) .
In the present study, we used data from a large Swedish cohort in which we previously reported that blood cadmium is associated with the prevalence and size of atherosclerotic plaques (13) . The aim was to investigate whether the association between smoking and plaque prevalence was mediated through cadmium and, if so, to quantify such an effect.
METHODS

Subjects
All men and women living in Malmö, Sweden, and born during 1923-1945 were invited to participate in the Malmö Diet and Cancer study between 1991 and 1996 (21) . A random sample (n = 6,103) was selected to form the Malmö Diet and Cancer cardiovascular cohort (22) . Data in the present study (on 4,639 subjects) are the same as used in Fagerberg et al. (13) .
During baseline visits, anthropometric measurements were performed, blood pressure was measured, and lifestyle factors, socioeconomic status, and medication were assessed using established questionnaires (22) . Study subjects underwent B-mode ultrasonography (Acuson 128 CT system; Siemens, Mountain View, California) of the right carotid artery, according to a standardized protocol, performed by trained, certified sonographers (22) . Atherosclerotic plaques were defined as a focal thickening of the intima-media complex of >1.2 mm and with an area of ≥10 mm 2 . Fasting blood samples were drawn and stored in a biobank.
Smoking status was classified into never smokers, longtime former smokers (stopped smoking >15 years ago), recent former smokers (stopped smoking ≤15 years ago), and current smokers. The rationale for dividing former smokers by the median of 15 years since smoking cessation was to take into consideration the well-established fact that smoking-associated risk of ischemic stroke and myocardial infarction seems to disappear within 5 years of quitting (23, 24) ; further, a crosssectional study from Guangzhou in southern China has shown that the risk of carotid plaques was attenuated after 10-19 years of smoking cessation (25) .
An individual was defined as having diabetes mellitus if reporting it in the questionnaire, reporting use of antidiabetic medication, or having a fasting, venous whole-blood glucose level of ≥6.1 mmol/L (110 mg/dL). Serum triglycerides and total cholesterol were measured on a DAX 48 automatic analyzer using reagents and calibrators provided by the supplier (Bayer Norden, Malmö, Sweden). Serum high-density lipoprotein cholesterol (HDL) was determined by the same procedure as for total cholesterol (TC) after precipitation of the other lipoproteins with dextran sulfate. Low-density lipoprotein cholesterol (LDL) was calculated according to Friedewald's formula (LDL = TC − HDL − (triglycerides/2.2)). A hexokinase method was used to determine blood glucose. High-sensitivity C-reactive protein (hs-CRP) was measured from frozen plasma samples using the Tina-quant CRP latex high-sensitivity assay (Roche Diagnostics, Rotkreuz, Switzerland) on an ADVIA 1650 chemistry system (Bayer Healthcare, Tarrytown, New York).
Frozen samples from the biobank were used to measure cadmium concentrations. In short, cadmium was analyzed by inductively coupled plasma mass spectrometry with an octopole reaction system, operated in the helium collision cell mode (details published previously (13)). The imprecision was 9.6% (the coefficient of variation for 50 duplicate samples). The limit of detection, calculated as 3 times the standard deviation of the blank, was 0.02 mg/L. None of the samples were below the limit of detection. All samples were analyzed with external quality-control samples included, and results were within recommended limits (13) . An interlaboratory comparison showed good agreement (13) .
The study was approved by the Ethics Committee of Lund University, Lund, Sweden (MDC LU 51-90). All participants provided informed consent.
Statistical analysis
To assess the relative importance of different pathways from exposure to outcome, we asked whether the effect of an exposure was mediated by variable M. For a variable to be considered a mediator, there should be a significant association between: 1) exposure and mediator, and 2) mediator and outcome. However, the consensus is that there need not be a significant association between exposure and outcome (direct and mediated effects may have opposite signs) (17, 18) .
Here, blood cadmium concentration was a potential mediator between smoking and atherosclerotic plaques. The dichotomous outcome was a function of smoking, cadmium, and different sets of covariates and confounders, C 1 , C 2 , . . .: in model 1, sex and age; in model 2, variables in model 1 with the addition of education (categorized as high or low), physical activity (high or low), and alcohol intake (grams/day); in model 3, variables in model 2 with the addition of waist circumference, systolic blood pressure, ratio of HDL cholesterol and total cholesterol (26), serum triglycerides, whole blood glucose, hs-CRP, treatment for hypertension, lipid-lowering treatment, and diabetes mellitus.
Decomposition. In this general description, the mediation terminology used is total, direct, and indirect effect. When presenting the results, the term "association" will be used because this is a cross-sectional study. The total effect (TE) of the exposure on a dichotomous outcome y, comparing Exp = 0 to Exp = 1 on the prevalence ratio (PR) scale, conditional on covariates C 1 , C 2 , . . ., can be defined by: where P(Y Exp=1 = 1) is the probability of having plaque when Exp = 1. This is abbreviated as:
If there is a mediating effect, the comparison between Exp = 0 and Exp = 1 is also associated with a change in the mediator level, from m 0 to m 1 . Had exposure been Exp = 0, the mediator would have had level m 0 . If exposure had been Exp = 1, the mediator would have had level m 1 . Therefore the expression for the total effect should include the change in mediator level:
which can be decomposed into the product of the prevalence ratios for natural indirect effect (NIE) and natural direct effect (NDE): The NIE assumes that the exposure is set to Exp = 1, after which we compare the outcome if the mediator had level m 0 to the outcome if the mediator had level m 1 . The NDE assumes that the mediator is set to m 1 , after which we assess the direct effect of the exposure (Exp = 0 versus Exp = 1). An illustration is given in Figure 1 . This is not a prospective study, and consequently we cannot make statements about the effect of smoking on the development of plaque, only about the association. The term "association" rather than "effect" is used, but the subscript abbreviations TE, NDE, and NIE are kept. The direct and indirect effects were estimated using the regression framework (27) (28) (29) .
Prevalence ratio as measure of association. The prevalence was expected to be high (>10%), so the odds ratio of a logistic regression would overestimate the risk ratio. The plaque prevalence was estimated using a generalized linear regression model, under assumption of an approximate Poisson distribution, the log link, and a robust variance estimate (30) (PROC GENMOD (SAS Institute, Inc., Cary, North Carolina); see Web Appendix 1, available at https://academic.oup.com/aje). The cadmium levels were log-transformed because of the highly skewed distribution. The regression models are given for log(prevalence) in the following 2 equations. Under assumption of no interaction between smoking and cadmium, we have:
where the probability of having plaque is a function of smoking (Smk), the possible mediator (Cd), and the set C of other covariates and confounders (C 1 , C 2 , . . .). If cadmium is a mediator, there is an association between the expected (logtransformed) cadmium level, E[log(Cd)], and smoking,
estimated using ordinary least squares regression (PROC GLM, SAS Institute Inc.). Generally when estimating the so-called NDE of the exposure, the mediator is set to the level it would have had given no exposure (31) (32) (33) . For the situation with no interaction, the prevalence ratio showing the natural direct association, log (PR NDE ), is given approximately as: A) The prevalence is higher for Exp = 1 (gray dot). Because there is an association between the exposure and the mediator, the mediator has level m 0 when Exp = 0 and level m 1 when Exp = 1. B) The shift from Exp = 0 (black dots) to Exp = 1 (gray dots) implies a change in the mediator level, from m 0 to m 1 . Because the outcome depends on both exposure and mediator, the total effect of a shift from Exp = 0 to Exp = 1 includes a shift from Med = m 0 to Med = m 1 . Therefore, log(prevalence) is expected to change from log(p Exp=0, Med=m0 ) to log(p Exp=1, Med=m1 ), which is the total effect (TE), of the exposure. C) The total effect can be separated into a natural direct effect (NDE); log(p Exp=1, Med=m0 ) − log(p Exp=0, Med=m0 ), and a natural indirect effect (NIE); log(p Exp=1, Med=m1 ) − log(p Exp=1, Med=m0 ).
capturing the direct association when comparing Exp = 0 to Exp = 1 when the mediator has level m 0 , given the covariates and confounders, C. The value m 0 is the "natural" level of the mediator for someone who is not exposed (
. ., the log cadmium level if the person had never smoked). The prevalence ratio showing the NIE, log(PR NIE ), can be estimated as:
where m 1 is the "natural" level of the mediator for someone who is exposed (
.).
Interaction between exposure and mediator. In equation 1, it is assumed that the association between plaque prevalence and log(Cd) is the same for all smoking groups. A model without interaction is illustrated in Figure 1 (parallel lines for Exp = 0 and Exp = 1). But with an interaction (equation 3), the association between the mediator and the outcome can differ between the exposure groups, indicating an "effect" modification. The term Smk · log(Cd), with parameter θ Smk_logCd , is added to equation (1), so that The natural indirect association can be estimated as:
and log(PR NDE ) can be estimated using an expression corresponding to the one in Valeri and VanderWeele (18) . Following VanderWeele and Vansteelandt (27) , the proportion mediated can be estimated as log(PR NIE )/(log(PR NDE ) + log (PR NIE )).
Prevalence difference as a measure of association. Instead of using the prevalence ratio as the measure of association, the difference can be used (risk difference (29, (34) (35) (36) ), If there is no interaction between smoking and cadmium (equation 1), the prevalence difference (PD) showing the total association, PD TE , can be estimated as: 
The PD NIE was estimated as PD TE − PD NDE . The proportion mediated can be estimated as PD NIE /PD TE . If there is an interaction (equation 3), PD NDE and PD TE are given in Web Appendix 2.
Mediation analysis was performed using the SAS macros by Valeri and VanderWeele (18) , modified to allow for a 4-category exposure variable and Poisson regression (30) . Bootstrap inference (1,000 bootstrap samples) was used to estimate the natural direct, natural indirect, and total association and confidence intervals.
RESULTS
The plaque prevalence ranged between 29% (never smokers) and 42% (current smokers), and the former smokers a Percentages are rounded to 2 significant digits. b Less than 9 years of schooling. c Leisure-time physical activity was assessed as a summary score from intensity and time spent for 18 activities during the preceding year; low physical activity was lowest summary-score quartile (Li et al. 2009 (49) ). started smoking at an early age (long-time former smokers, mean = 20 years; recent former smokers, mean = 23 years; and current smokers, mean = 24 years) ( Tables 1 and 2) .
Three different sets of covariates and confounders were considered (models 1-3). All the analyses were based on the observations available for model 3 (n = 4,009). The median cadmium level was 0.26 μg/L (interquartile range, 0.17-0.50).
The estimated association between smoking and plaques (θ Smk ) was stronger when cadmium was not included, especially for current smokers (Figure 2 ). This may suggest that part of the association with smoking is mediated by cadmium.
The cadmium levels differed between never smokers, long-time former smokers, recent former smokers, and current smokers, with crude geometric means of 0.20 μg/L, 0.20 μg/L, 0.30 μg/L, and 0.82 μg/L ( Table 2 ). The association between the possible mediator cadmium and the exposure smoking was significant for recent former smokers (P 2-sided < 0.0001) and current smokers (P 2-sided < 0.0001). The ratios of the adjusted geometric means were 1.08, 1.60, and 4.28, for model 2 (Figure 3) .
The interaction was significant both for recent former smokers (θ Smk1b_logCd , P < 0.01) and for current smokers (θ Smk2_logCd , P ≤ 0.005) ( Table 3 ). This indicates that the association with cadmium differed between the smoking groups, and that equation 3 (including interaction) was appropriate for the mediation analysis.
The natural direct association between plaques and having stopped smoking a long time before (>15 years) had a prevalence ratio (PR NDE ) of between 1.19 and 1.21 (the risk for a long-time former smoker to have plaque was 19%-21% higher than that for a never smoker). For this group, the association was not mediated through cadmium. The recent former smokers (≤15 years ago) had a PR NDE of 1.15 and a significant indirect association. Of the total association, approximately 45% was mediated through cadmium. The current smokers had a PR NDE of 1.16-1.17, with a significant indirect association; Figure 2 . The estimated prevalence ratio showing the association between smoking status and plaque, using data from Swedish Malmö Diet and Cancer cohort (1991) (1992) (1993) (1994) (1995) (1996) . The prevalence ratio was estimated using model 1 (left), model 2 (middle), and model 3 (right), which considered different sets of covariates and confounders. The white bars show the prevalence ratio for long-time former smokers versus never smokers, the gray bars show the prevalence ratio for recent former smokers versus never smokers, and the black bars show the prevalence ratio for current smokers versus never smokers. The models that included both cadmium and smoking ("with") estimated the direct association with smoking. The models that included only smoking ("without") estimated the total association with smoking.
approximately 65% of the total association was mediated through cadmium (Table 4) . For a model without interaction between exposure and mediator, the indirect association was smaller (but significant) for recent former smokers and current smokers, and the proportions mediated were 20% and 35% respectively (Web Table 1 ).
In the mediation analysis above, resampling (1,000 bootstrap samples) and bootstrap inference were used. For comparison, the observed data set (without resampling) was also used to estimate the associations, using both PD and prevalence ratio (log transformed) (Figure 4) Tables 2 and 3) .
Independent of the measure of association (ratio or difference), the relationship between natural indirect and direct associations was similar (Figure 4) . The estimated adjusted prevalences of plaque were approximately 27% (never smokers), 32% (long-time former smokers), 34% (recent former smokers), and approximately 41% (current smokers), as summarized in Figure 5 . The total absolute contributions of smoking to plaque prevalence were approximately 5% (long-time former smokers), approximately 8% (recent former smokers), Ratio of Geometric Mean for Cadmium Model Figure 3 . The estimated adjusted association between smoking status and the mediator blood cadmium, using data from Swedish Malmö Diet and Cancer cohort (1991) (1992) (1993) (1994) (1995) (1996) . Equation 2 was used in the estimation. The graph shows the ratio of the geometric means for cadmium exposure, in relation to the never smokers. The white bars show the ratio for long-time former smokers versus never smokers, the gray bars show the ratio for recent former smokers versus never smokers, and the black bars show the ratio for current smokers versus never smokers. 
Adjusted for sex and age. d Adjusted for sex, age, education (high or low), physical activity (high or low), and alcohol intake (grams/day). e Adjusted for sex, age, education (high or low), physical activity (high or low), alcohol intake (grams/day), waist circumference, systolic blood pressure, ratio of high-density lipoprotein cholesterol and total cholesterol, serum triglycerides, whole blood glucose, high-sensitivity C-reactive protein, treatment for hypertension, lipid-lowering treatment, diabetes mellitus, and hormone therapy.
and approximately 14% (current smokers), and the indirect absolute contributions, mediated through cadmium, were 0%, 4%, and 10%, respectively (using model 2), as shown in Figure 4B .
DISCUSSION
We used data from baseline in a Swedish cohort study to assess the association between smoking and atherosclerotic plaques. Our hypothesis was that a part of the association with smoking was mediated through high blood cadmium levels. The total association was split into direct and indirect associations and the proportion mediated was estimated. Both current smokers and recent former smokers (with cessation <15 years ago) had a significant indirect association, where 40%-65% of the association was mediated through cadmium.
The direct association between plaque prevalence and smoking status was similar between recent former smokers and long-time former smokers (PR NDE in model 2 = 1.20 and 1.15, respectively). However, only the recent former smokers had an indirect association (PR NIE = 1.12); the cadmium levels of the long-time former smokers were the same as those of the never smokers and therefore created no indirect association.
These results raise several questions: How does smoking cessation affect carotid plaques? The cross-sectional, fairly small Chinese study mentioned above (25) , indicated attenuated plaque prevalence 10-19 years after smoking cessation. One long-term prospective study has been based on the present cohort. The results showed that 6-9 years after quitting there was a decrease in the rate of lumen reduction in the carotid artery (37) . In a prospective study on atherosclerosis of the abdominal aorta, there was still an excess risk of plaque progression 5-9 years after smoking cessation (38) . However, there is to our knowledge no published prospective study on carotid plaque prevalence after smoking cessation lasting for several decades.
In addition, how does smoking cessation affect the associated proatherosclerotic mechanisms? As shown here, more than 15 years of smoking cessation was associated with blood cadmium levels similar to levels in never smokers. But after smoking cessation, blood cadmium decreases more rapidly 
. ., estimated using Poisson distribution, log link, and bootstrap estimation with 1,000 replicates.
b Adjusted for sex and age. c Adjusted for sex, age, education (high or low), physical activity (high or low), and alcohol intake (grams/day). d Adjusted for sex, age, education (high or low), physical activity (high or low), alcohol intake (grams/day), waist circumference, systolic blood pressure, ratio of high-density lipoprotein cholesterol and total cholesterol, serum triglycerides, whole blood glucose, high-sensitivity C-reactive protein, treatment for hypertension, lipid-lowering treatment, diabetes mellitus, and hormone therapy. e m 0 = (β 0 + β Smk · 0 + β 1 · C 1 + . . .); σ 2 is the residual variance from regression in equation 2. f Proportion mediated was estimated as log(PR NIE )/(log(PR NDE ) + log(PR NIE )).
than the body burden of cadmium, as shown by the much longer half-life for urinary cadmium (3, 4) . For example, there are no data on a possible concomitant change in cadmium concentrations in the carotid plaques. However, although the cadmium concentrations in symptomatic carotid plaques are 50-fold higher than those in blood, and highest in the more vulnerable upstream part (14) , the relevance of cadmium in plaques for plaque occurrence has not been proven. Taken together, there is a lack of background data that would make it possible to understand the very long-term direct effect of smoking on plaque prevalence and the suggested more short-term effects of cadmium.
Our results show an association between plaque and smoking among long-time former smokers, which is seemingly in contrast to the established concept that cardiovascular risk related to smoking disappears less than 10 years after smoking cessation. The explanation to this seeming contradiction is related to mechanisms by which atherosclerotic plaques become much less prone to rupture at the same time as blood becomes less procoagulant after smoking cessation. As a result, the smoking-related risk of plaque rupture and formation of thrombosis, leading to overt cardiovascular diseases, disappears whereas these plaques still remain in the vascular wall.
The assumption of an interaction between smoking status and cadmium levels, used in the mediation analysis, is biologically plausible: Cadmium is proinflammatory, irrespective of whether the source is cigarette smoke or diet (39) , and cigarette smoke also contains many additional proinflammatory compounds that may contribute to its atherogenic potential.
In addition to cadmium, carbon monoxide (CO) is another toxic substance in cigarette smoke, analyzed as a risk factor for cardiovascular events and atherosclerosis in two cohorts. Among smokers, there was a significant association between carbon monoxide and both cardiovascular incidence and peripheral vascular disease (40) . Among never smokers, the cardiovascular risk was found to be higher for those with high levels of carboxyhemoglobin (COHb%) (41) . The mechanism might be that smoking affects carbon monoxide, which causes inflammation, which in turn increases the risk. This is shown in Lind et al. (42) , where carboxyhemoglobin among smokers was related to levels of inflammation-sensitive proteins, which in turn were related to increased cardiovascular risk.
Under the counterfactual framework, the causal effect is the difference in outcome if the same individual was exposed versus unexposed (31) . Naturally, for an individual, the outcome is observed under only one of these conditions. We have Prevalence Difference Model Figure 4 . The direct and indirect association with smoking status, using data from Swedish Malmö Diet and Cancer cohort (1991) (1992) (1993) (1994) (1995) (1996) . The associations are presented as (log transformed) prevalence ratios (A) and prevalence differences (B). In each graph, the left group shows long-time former smokers versus never smokers, the middle group shows recent former smokers versus never smokers, and the right group shows current smokers versus never smokers. The black bars show the direct association, and the gray bars show the indirect association. Parameters were estimated under assumption of an interaction between smoking and cadmium (equation 3), using the observed data set (no resampling). Estimated Prevalence Model Figure 5 . The estimated prevalence of plaque in the different smoking groups, adjusted for covariates, using data from Swedish Malmö Diet and Cancer cohort (1991) (1992) (1993) (1994) (1995) (1996) . Prevalence was estimated under assumption of an interaction between smoking and cadmium (equation 3), using the observed data set (no resampling). Smoking groups were: never smokers (white), long-time former smokers (light gray), recent former smokers (dark gray), current smokers (black).
presented results on the natural direct effect/association of smoking rather than on the controlled direct effect/association. The NDE is estimated conditional on the mediator being at the level that is expected if the person had not been exposed. The controlled direct effect is the exposure effect when the mediator is controlled for all subjects at a prespecified level. The natural effect is of greater interest in evaluating the action of various mechanisms (18) , whereas the controlled effect is of interest for evaluating a policy. Causal inference is based on the assumption of no unmeasured confounding; for exposure-outcome, for mediatoroutcome, and for exposure-mediator. A possible confounder for the smoking-plaque relationship is socioeconomic status, and therefore we included a variable for education. A possible confounder in the cadmium-plaque relationship could be consumption of food with high cadmium content, which is often considered healthy (e.g., vegetables and whole grains). The fiber content of healthy food should have an inverse association with plaque occurrence.
Bias in the effect estimate can occur because of misclassification (43) . Former smokers may, for example, incorrectly report their year of smoking cessation. Random misclassification leads to attenuation-both β Smk and θ Smk being biased towards null. A simplified calculation, assuming no interaction, suggests that, if the attenuation of β Smk is larger than that of θ Smk , the proportion mediated would be underestimated and vice versa.
There are several limitations in our study. The crosssectional design makes it difficult to make causal claims. The participants were selected at random from the cohort, and plaque was measured objectively in 76%. The participants were unaware of the outcome and of their blood cadmium level. Therefore we do not expect any selection bias within the cohort. Important for causality is the timeliness of smoking, cadmium exposure, and plaque development. Because both cadmium and plaque were measured at the same time, we could not model the progression of plaque development from baseline to follow-up as a function of cadmium at baseline. However, even though this is a cross-sectional study, it is well established that start of smoking causes a rapid increase in cadmium exposure. Here the mean age for the start of smoking was 22.5 years-several decades before this study. The Norwegian Tromsö study showed that the prevalence of carotid plaques in the age group 25-34 years was only 2%-3% (44) . This indicates that cadmium exposure preceded subclinical plaque development in the vast majority of cases in the present study.
Another limitation concerns the data on smoking habits. We had no complete information on pack-years as a measure of total smoking burden. Data from a large US study have indicated that pack-years carry information on exposure that is superior to smoking categorization (never, previous, and current smoking) as regards carotid atherosclerosis (45) . Neither did we have data on exposure to environmental tobacco smoke, which has been shown to enhance the progression of carotid atherosclerosis (37, 45) . Self-reported smoking habits are at risk of bias and there were no objective measurements of current smoking. However, previous validation studies of self-assessed smoking have shown satisfactory results with regard to current and former smoking (46) . There were no established definitions of carotid plaque during 1991-1994. Only the right carotid artery was scanned due to financial limitations and limited availability of trained ultrasonographers with experience in research (22) . This is a potential limitation. Also, carotid plaque was defined as a focal intima-media thickness protrusion of at least 1.2 mm, which is somewhat less than the definition by American Society of Echocardiography (47) and Mannheim (i.e., ≥1.5 mm). However, the prevalence of plaque in this study is similar to, for example, the Atherosclerosis Risk in the Community study, which scanned both sides (48) .
By using mediation analysis in a large population study, we were able to identify a direct and an indirect pathway between smoking and the prevalence of carotid plaques. This indirect association, mediated by cadmium, was observed among current smokers and former smokers who had quit smoking less than 15 years ago. Mediation analysis seems to be valuable tool in the complicated work of clarifying the pathophysiological role of cadmium exposure in cardiovascular diseases caused by tobacco smoking.
